Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

3 Numbers That Explain Bristol Myers Squibb's Dirt Cheap Valuation

With this pharma company trading for less than 10 times earnings, the market remains very uncertain about its stock and looming patent cliff.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at fool.com →

More in Finance & Markets

Transaction in Own Shares

Transaction in Own Shares September 28, 2026 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 28 September 2026 it purchased the following number of Shares for cancellation.

More from Tuesday 29 September →